GLP-1 receptors are found throughout the body, including in the immune system and the brain, which might explain their anti-inflammatory and pain-modulating effects for conditions such as endometriosis
Its triple GIP/GLP-1/glucagon agonist mechanism produced the most striking weight-loss numbers ever reported in a Phase 2 trial of an injectable peptide, and its broad TRIUMPH Phase 3 program is poised to expand understanding of how triple receptor modulation affects obesity, diabetes, liver disease, cardiovascular risk, sleep apnea, and musculoskeletal health
Retatrutide is different because it is designed to activate three related receptor pathways
Learn more about how the Gallup National Health and Well-Being Index works
Given that BSO possesses non-specific pharmacological activities, the authors concluded that this effect was independent of the inhibition of GSH biosynthesis 15